These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6744624)

  • 61. Use of succinylcholine in the presence of atypical cholinesterase.
    Lee-Son S; Pilon RN; Nahor A; Waud BE
    Anesthesiology; 1975 Oct; 43(4):493-6. PubMed ID: 1180409
    [No Abstract]   [Full Text] [Related]  

  • 62. [Relation between serum cholinesterase and duration of the succinylcholine effect in the man. Preliminary note].
    Appiani L; Carelli S; Dvelaickis D; Laveneziana D
    Quad Sclavo Diagn; 1971 Mar; 7(1):333-5. PubMed ID: 5155192
    [No Abstract]   [Full Text] [Related]  

  • 63. [Isolation and partial characterization of a cholinesterase (CHE) isoenzyme from horse serum].
    Stosiek U; Hardegg W
    Pflugers Arch; 1969; 307(2):R5-6. PubMed ID: 5814873
    [No Abstract]   [Full Text] [Related]  

  • 64. Relationship between serum cholinesterase activity and duration of succinylcholine action in subjects with the "usual" phenotype for the enzyme.
    Yücel D; Top S; Erdemli O; Oğüş H
    Clin Chem; 1988 Dec; 34(12):2579-80. PubMed ID: 3197311
    [No Abstract]   [Full Text] [Related]  

  • 65. Preoperative serum cholinesterase concentration in chronic renal failure. Clinical experience of suxamethonium in 81 patients undergoing renal transplant.
    Ryan DW
    Br J Anaesth; 1977 Sep; 49(9):945-9. PubMed ID: 911595
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Serum cholinesterase isoenzyme studies in diseases of the liver, biliary tract and pancreas].
    Kiss S; Szécsey G; Szabó J
    Orv Hetil; 1975 Dec; 116(50):2936-8. PubMed ID: 1196633
    [No Abstract]   [Full Text] [Related]  

  • 67. [Practical importance of plasma cholinesterase determination and its atypical behavior in relation to succinylbischoline].
    DOENICKE A; HOLLE F; FREY HH
    Anaesthesist; 1962 May; 11():146-50. PubMed ID: 13886905
    [No Abstract]   [Full Text] [Related]  

  • 68. Atypical plasma cholinesterase, succinylcholine, and prolonged apnea.
    Richardson RB; Smith JC; Derrick WS
    South Med J; 1974 Sep; 67(9):1118-20. PubMed ID: 4850696
    [No Abstract]   [Full Text] [Related]  

  • 69. Correlation of succinylcholine duration of action with plasma cholinesterase activity in subjects with the genotypically normal enzyme.
    Viby-Mogensen J
    Anesthesiology; 1980 Dec; 53(6):517-20. PubMed ID: 7457973
    [No Abstract]   [Full Text] [Related]  

  • 70. A cholinesterase isoenzyme of fetal origin: a potential diagnostic marker.
    Jones SR; Evans SE
    Lancet; 1983 Feb; 1(8321):412. PubMed ID: 6130397
    [No Abstract]   [Full Text] [Related]  

  • 71. [Application to an automatic system of a direct method for determining atypical variants of cholinesterase using succinyldithiocholine as substrate].
    Capone G; Gnudi D; Pensabeni L; Martelli AM; Marconi MC; Accorsi A
    Quad Sclavo Diagn; 1988; 24(1-4):189-96. PubMed ID: 3268911
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Effect of neuroleptanalgesia preparations and succinylcholine derivatives on human blood serum cholinesterase].
    Fridliand MI
    Anesteziol Reanimatol; 1980; (1):17-9. PubMed ID: 7377608
    [No Abstract]   [Full Text] [Related]  

  • 73. [Research on serum cholinesterase activity in subjects with prolonged apnea caused by succinylcholine].
    Patané S; Bellelli M; Russo S; Arcerito S
    Acta Anaesthesiol; 1967; 18():Suppl 2:63+. PubMed ID: 5632256
    [No Abstract]   [Full Text] [Related]  

  • 74. Properties of "usual" and "atypical" serum cholinesterases using o-nitrophenyl butyrate as substrate.
    Whittaker M; Hardisty CA
    Clin Chem; 1969 Jun; 15(6):445-51. PubMed ID: 5786800
    [No Abstract]   [Full Text] [Related]  

  • 75. Isoniazid and psuedocholinesterase polymorphisms.
    La Du BN
    Fed Proc; 1972; 31(4):1276-85. PubMed ID: 4556778
    [No Abstract]   [Full Text] [Related]  

  • 76. [Degradation of the curare-like action of succinylcholine by a cholinesterase reactivator].
    Betti V
    Minerva Anestesiol; 1967 Feb; 33(2):159-61. PubMed ID: 5602387
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of quinidine on plasma cholinesterase activity and succinylcholine neuromuscular blockade.
    Kambam JR; Franks JJ; Naukam R; Sastry BV
    Anesthesiology; 1987 Nov; 67(5):858-60. PubMed ID: 3674502
    [No Abstract]   [Full Text] [Related]  

  • 78. STUDIES ON FORMAL GENETICS OF THE PSEUDO-CHOLINESTERASE POLYMORPHISM; AN ATYPICAL SEGREGATION IN A FAMILY.
    GOEDDE HW; FUSS W; GEHRING D; BAITSCH H
    Biochem Pharmacol; 1964 Apr; 13():603-8. PubMed ID: 14191866
    [No Abstract]   [Full Text] [Related]  

  • 79. Correlation of plasma cholinesterase activity and duration of action of succinylcholine during pregnancy.
    Blitt CD; Petty WC; Alberternst EE; Wright BJ
    Anesth Analg; 1977; 56(1):78-83. PubMed ID: 556913
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dose-response relationship for succinylcholine in a patient with genetically determined low plasma cholinesterase activity.
    Smith CE; Lewis G; Donati F; Bevan DR
    Anesthesiology; 1989 Jan; 70(1):156-8. PubMed ID: 2912300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.